BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Given Imaging Ltd. Announces Participation at Upcoming Investor Conferences

  November 8, 2010

   · 

  4 min read
• Deals

  MedGenesis Therapeutix Reacquires Rights for GDNF

  November 8, 2010

   · 

  1 min read
• Business

  Concord Medical Services Holdings Limited to Report Third Quarter 2010 Financial Results on Thursday, November 18, 2010

  November 8, 2010

   · 

  1 min read
• Business

  Vivakor, Inc. Announces Relocation of Executive Offices and Investor Outreach Initiatives

  November 8, 2010

   · 

  1 min read
• Drug Development

  Athersys, Inc. Announces FDA Authorization of Phase II Clinical Trial for Inflammatory Bowel Disease With Pfizer Inc. Regenerative Medicine

  November 8, 2010

   · 

  1 min read
• Mom’s Sleep No Worse With Breastfeeding

  November 8, 2010

   · 

  1 min read
• Business

  Plasticell Signs Collaboration With UCB, Inc. First in Kind Deal to Partner Small Molecule Drugs for Stem Cell Research

  November 8, 2010

   · 

  3 min read
• Drug Development

  Boehringer Ingelheim GmbH’s Drug Lowers Bleeding Risk in Those Who Had Stroke

  November 8, 2010

   · 

  1 min read
• Deals

  French Biotech LFB Biotechnologies to Buy GTC Biotherapeutics; GTC Agrees to go Private for $.30 Per Share

  November 8, 2010

   · 

  2 min read
• Drug Development

  Pfizer Inc.: In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function

  November 8, 2010

   · 

  8 min read